tiprankstipranks
Trending News
More News >
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM
US Market

Mirum Pharmaceuticals (MIRM) Income Statement

Compare
704 Followers

Mirum Pharmaceuticals Income Statement

Last quarter (Q3 2025), Mirum Pharmaceuticals's total revenue was $133.01M, an increase of 47.17% from the same quarter last year. In Q3, Mirum Pharmaceuticals's net income was $2.90M. See Mirum Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 336.89M$ 186.37M$ 77.06M$ 19.14M$ 0.00
Gross Profit
$ 255.25M$ 139.34M$ 64.69M$ 17.23M$ -623.00K
Operating Expenses
$ 342.85M$ 248.49M$ 195.91M$ 190.65M$ 103.67M
Depreciation and Amortization
$ 23.63M$ 10.83M$ 3.24M$ 975.00K$ 623.00K
EBITDA
$ -48.97M$ -136.49M$ -122.85M$ -65.39M$ -102.31M
Operating Income
$ -87.61M$ -109.15M$ -131.22M$ -173.41M$ -104.30M
Other Income/Expenses
$ 694.00K$ -53.27M$ -10.85M$ 89.46M$ 1.03M
Pretax Income
$ -86.91M$ -162.42M$ -142.07M$ -83.95M$ -103.26M
Net Income
$ -87.94M$ -163.41M$ -135.66M$ -83.99M$ -103.27M
Per Share Metrics
Basic EPS
$ -1.85$ -4.00$ -4.01$ -2.77$ -4.09
Diluted EPS
$ -1.85$ -4.00$ -4.02$ -2.77$ -4.09
Weighted Average Shares Outstanding
47.52M 40.89M 33.84M 30.32M 25.25M
Weighted Average Shares Outstanding (Diluted)
47.52M 40.89M 33.98M 30.32M 25.25M
Currency in USD

Mirum Pharmaceuticals Earnings and Revenue History